Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response. (Q39763286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

eradication of infectious diseases

15 January 2020

main subject

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Javier Briones Meijide

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

E Alvarez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

E Moga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J Sierra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

10 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

469-477

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010627%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cells and the control of immunity

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

DNA fusion gene vaccines against cancer: from the laboratory to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Functions of CD40 on B cells, dendritic cells and other cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Cell fusion: from hybridoma to dendritic cell-based vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

IL-17 family cytokines and the expanding diversity of effector T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Cytokine mediators of Th17 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Th17 cells in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

IL-23 drives pathogenic IL-17-producing CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021

Type 17 CD8+ T cells display enhanced antitumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.150

7 January 2021